MedTrace Logo

Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma

NCT01510600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2016-05-19

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers in samples from patients with high-risk neuroblastoma.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

polymerase chain reaction

OTHER

laboratory biomarker analysis

OTHER

medical chart review

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Loretta Lau, MD · Sydney Children's Hospitals Network

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01510600 on ClinicalTrials.gov